CooperCompanies appoints Paul Keel to its Board
Appointment effective July 1, 2026. Keel, CEO of Envista, joins Audit Committee. His medical device leadership experience aids strategy execution.
See the latest news and media coverage for CooperCompanies. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global medical device company for vision and reproductive health
coopercos.comLast updated
In short: CooperCompanies reported record revenue and raised its 2026 guidance, despite a significant litigation charge related to CooperSurgical settlements.
Appointment effective July 1, 2026. Keel, CEO of Envista, joins Audit Committee. His medical device leadership experience aids strategy execution.
This CooperVision program reduces carbon impact in MyDay® products through sustainable materials, process improvements, and Plastic Bank partnership.
Revenue reaches $1.024 billion, up 6%; non-GAAP EPS hits $1.10, up 20%. Raises full-year guidance.
The lens, authorized by Japan's Ministry of Health, corrects myopia and slows progression in children. It reduces progression by 59% over three years.
Explore more price target data and ratings for The Cooper Companies, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for...
Earlier this month, The Cooper Companies reported second-quarter 2026 results showing sales rising to US$1,081.5 million from US$1,002.3 million a year earlier, but swinging from...
CEO Albert White reported "a strong start to the fiscal year, highlighted by product launches, outstanding profitability and robust cash flow." White emphasized progress on...
Earlier this week, The Cooper Companies reported second-quarter 2026 results showing record sales of US$1,081.5 million but a net loss of US$77.9 million, largely due...
Track CooperCompanies and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.